Safety of trastuzumab (Herceptin®) during pregnancy: Two case reports

Cases Journal

Volumn 2, Issue 12, 2009, Pages

  Goodyer, Matthew J ^a   Ismail, Jeffri R M ^b   O'Reilly, Seamus P ^a   Moylan, Eugene J ^a   Ryan, C Anthony M ^a   Hughes, Paul A F ^b   O'Connor, Alan ^a  

^a University College Cork and INFANT Centre   (Ireland)

^b University College Cork   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; TRASTUZUMAB;

ADULT; ARTICLE; BREAST CANCER; CASE REPORT; CHILD; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; MASTECTOMY; NEWBORN; PREGNANCY; PRENATAL DRUG EXPOSURE; PRESCHOOL CHILD;

EID: 77953399177     PISSN: 17571626     EISSN: None     Source Type: Journal    
DOI: 10.1186/1757-1626-2-9329     Document Type: Article

References (17)

1. Simister NE: Placental transport of immunoglobulin G. Vaccine 2003, 21:3365-9.
2. cited by Mir O, Berveiller P, Pons G: Trastuzumab - mechanism of action and use. N Engl J Med 2007, 357(16):1664-5.
3. Friedrichs B, Tiemann M, Salwender H, Verpoort K, Wenger MK, Schmitz N: The effects of rituximab treatment during pregnancy on a neonate. Haematologica 2006, 91:1426-7.
4. cited by Mir O, Berveiller P, Pons G: Trastuzumab - mechanism of action and use. N Engl J Med 2007, 357(16):1664-5.
5. Vasiliauskas EA, Church JA, Silverman N, Barry M, Targan SR, Dubinksy MC: Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn. Clin Gastroenterol Hepatol 2006, 4:1255-8.
6. cited by Mir O, Berveiller P, Pons G: Trastuzumab - mechanism of action and use. N Engl J Med 2007, 357(16):1664-5.
7. Bader AA, Schlembach D, Tamussino KF, Pristauz G, Petru E: Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy. Lancet Oncology 2007, 8(1):79-81.
8. Watson WJ: Herceptin (trastuzumab) therapy during pregnancy: association with reversible anhydramnios. Obstetrics and Gynecology 2005, 105(3):642-3.
9. Herceptin Prescribing Information. Genentech, Inc. 2008.
10. Piccart-Gebhart MJ, Procter M, Leyland-Jones B, Goldhirsch A, Untch M, Smith I, Gianni L, Baselga J, Bell R, Jackisch C, Cameron D, Dowsett M, Barrios CH, Steger G, Huang CS, Andersson M, Inbar M, Lichinitser M, Láng I, Nitz U, Iwata H, Thomssen C, Lohrisch C, Suter TM, Rüschoff J, Suto T, Greatorex V, Ward C, Straehle C, McFadden E, Dolci MS, Gelber RD: Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 2005, 353(16):1659-72.
11. Kelly HL, Collichio FA, Dees EC: Concomitant pregnancy and breast cancer: options for systemic therapy. Breast Disease 2006, 23:2005-95.
12. Fanale MA, Uyei AR, Theriault RL, Adam K, Thompson RA: Treatment of metastatic breast cancer with trastuzumab and vinorelbine during pregnancy. Clinical breast cancer 2005, 6(4):354-6.
13. Waterston AM, Graham J: Effect of adjuvant trastuzumab on pregnancy. Journal of Clinical Oncology 2006, 24(2):321-2.
14. Shrim A, Garcia-Bournissen F, Maxwell C, Farine D, Koren G: Favorable pregnancy outcome following trastuzumab (Herceptin) use during pregnancy - Case report and updated literature review. Reproductive toxicology 2007, 23(4):611-3.
15. Sekar R, Stone PR: Trastuzumab use for metastatic breast cancer in pregnancy. Obstetrics and Gynecology 2007, 110(2 Pt 2):507-10.
16. Witzel ID, Müller V, Harps E, Janicke F, Dewit M: Trastuzumab in pregnancy associated with poor fetal outcome. Annals of Oncology 2008, 19(1):191-2.
17. Pant S, Landon MB, Blumenfeld M, Farrar W, Shapiro CL: Treatment of breast cancer with trastuzumab during pregnancy. Journal of Clinical Oncology 2008, 26(9):1567-9.